With a unique understanding of the CNS market for over 35 years, Neuraxpharm develops and commercializes value added medicines, standard generics and Consumer Healthcare products, e.g. nutraceuticals and probiotics in Europe.
We are continuously striving to offer a wide range of effective, high quality and affordable CNS treatments aimed at patients as well as health professionals and industry partners.
Additionally, through our manufacturing companies Lesvi and Inke, Neuraxpharm has an international presence in over 50 countries. We provide industry partners with finished dosage forms (FDFs) across multiple technologies and niche active pharmaceutical ingredients (APIs) using our expertise in the CNS and the respiratory areas.
Neuraxpharm develops and commercializes branded and generic CNS pharmaceuticals and nutraceuticals for the treatment and prevention of CNS disorders in main European countries
Neuraxpharm also owns and operates two manufacturing plants in Spain